Sharada Labadie,Jun Li,Jun Liang,Daniel Fred Ortwine,Xiaojing Wang,Jason Zbieg,Steven P. Govek,Mehmet Kahraman,Johnny Y. Nagasawa,Nicholas D. Smith
申请号：
US14972336
公开号：
US20160175284A1
申请日:
2015.12.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are compounds that are estrogen receptor modulators of Formula I:and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
